中国结合医学杂志（英文版）Chinese Journal of Integrative Medicine

Author Name	Affiliation	E-mail
Jia He	Tianjin University of Traditional Chinese Medicine, Tianjin, 300193, China
Yihyun Kwon	National University of Health Sciences, 200 East Roosevelt, Rd., Lombard, IL, 60148, USA
Chao Li	Tianjin University of Traditional Chinese Medicine, Tianjin, 300193, China
Xue-qi Zhang	Tianjin University of Traditional Chinese Medicine, Tianjin, 300193, China
Jian-guo Zhao	Department of Neurology of Integrated Traditional Chinese and Western Medicine, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, 300193, China	zjg525252@163.com

Hits: 1096

Download times: 0

Abstract:

Nowadays, a great number of traditional Chinese patent medicine (TCPM) are used more and more widely to treat cerebral infarction in China. When great attention is paid to using TCPM in the real world, several problems can be identified: ignoring the Chinese medicine (CM) therapeutic principle based on syndrome differentiation, a lack of appropriate dosage and usage based on individual patient conditions, and a shortage of evidence from randomized, double-blind, placebo-controlled clinical trials. Furthermore, in terms of evaluation of the TCPM effectiveness, few comprehensive criteria and evaluation methods recognized by the international community exist. This article addresses some opinions regarding the above mentioned problems.